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ICD-9 code 163 (malignant neoplasm of pleura) listed as underlying cause of death detected only 40% of Scottish mesothelioma
cases (all body sites) from the cancer registry in 1981–1999. This is lower than both the previously published 55% figure, derived
from UK mesothelioma register data 1986–1991, which is based on any mention of mesothelioma on death certificates, cross-
referenced to cancer registry data, and the 44% figure derived from Scottish mortality data 1981–1999, which captured any mention
of mesothelioma on the death certificate. Detection from cancer registry data increased to 75% under ICD-10 in Scotland, confirming
earlier predictions of the benefit of ICD-10’s more specific mesothelioma codes. Including the accidental poisoning codes E866.4
(ICD-9) and X49 (ICD-10), covering poisoning by ‘unspecified’ and ‘other’ causes, which appear to have been used as coding
surrogates for mesothelioma when asbestos exposure was explicitly mentioned in deaths suggestive of a mesothelioma, and which
are recorded as the underlying cause of death in 4–7% of mesotheliomas, may improve the mesothelioma detection rate in future
epidemiological studies.
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Mesotheliomas predominantly occur in males and in the pleura
(Britton, 2002). The vast majority are caused by occupational
exposure to asbestos (Peto et al, 1999). Incidence rates from UK
cancer registries are based on histological, cytological and
radiological information from a range of sources, including
hospital discharge records and death certificates, the histological
information extending beyond the standard International Classi-
fication of Diseases (ICD) codes. In contrast, electronic national
death records, abstracted from hand-written death certificates,
from which most mortality data are derived, are usually restricted
to the standard ICD codes available at the time of death. ICD-9 was
used in Scotland between 1979 and 1999, and ICD-10 from 1st
January 2000. In part I of British death certificates, as in many
other countries, a series of events are listed, the last of which
should be the underlying cause of death. In part II significant
conditions, diseases or events contributing to death, but not part
of this sequence of events may also be listed. Despite WHO
guidelines for uniformity in coding practices, for example, with
regard to which of the items listed in part I or part II is chosen as
the underlying cause of death, significant international variation is
recognised (Percy and Dolman, 1978).
Epidemiological studies of mortality have been hampered by the
lack of standardised specific codes for mesothelioma before the
introduction of ICD-10. Although certain countries (including
Scotland) have added supplemental codes or text fields to their
death records to record any mention of mesothelioma within the
hand-written certificates, this has not been uniform international
practice. The majority of studies have, instead, used ICD-9 code
163 (malignant neoplasm of pleura) as a surrogate for ‘mesothe-
lioma’ in electronic databases (Davis et al, 1992; Peto et al, 1999;
Pinheiro et al, 2003). To assess this as a surrogate for
mesothelioma, we used Scottish national data, which permits
direct linkage of individual patient data from cancer registry and
death records, to identify mesothelioma cases and then the codes
ultimately used for underlying cause of death in these patients. In
addition, by comparing the cause of death codes for cancer
registry-listed mesothelioma patients dying between 1981 and 1999
and between 2000 and 2003, we explored the impact of the
introduction of ICD-10 on this issue within the UK.
METHODS
Information Services of NHS Scotland (ISD) routinely produces a
data set containing SMR6 (Cancer Registration Records) and
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linked together using ‘probability matching.’ At the time of
analysis a full data set was available from 1981 to 2002 for cancer
registrations and 1981–2003 for deaths. It is estimated that the
probability-matching algorithm, which uses all available identify-
ing information (eg name, date of birth, postcode, hospital/patient
reference number), links these records with an accuracy of 98%
(Kendrick and Clarke, 1993). Before approximately 1997, five
autonomous cancer registries within Scotland, working in slightly
different ways, fed their data to ISD to generate the SMR6 database.
The West of Scotland relied heavily on hospital medical record
departments, supplemented by death records with any mention of
cancer. In contrast the other four registries relied more heavily on
histological data, supplemented by hospital records and death
certificate data. Since 1997, registration has been centralised at
ISD, using sources that include pathology records, hospital
discharge records, death records, and notifications from private
hospitals. The ICD codes used for underlying cause of death were
quantified for the 2740 mesothelioma patients (all body sites)
listed on the cancer registry who died between 1981 and 2003.
RESULTS
The top 10 ICD codes used for underlying cause of death in the
2133 mesothelioma patients recorded in the cancer registry who
died between 1981 and 1999 (ICD-9), and for the 607 who died
between 2000 and 2003 (ICD-10) are shown in Table 1.
DISCUSSION
A broad range of ICD-9 and ICD-10 codes have been used in
codifying the underlying cause of death among mesothelioma
patients in Scotland since 1981 (Table 1). Between 1981 and 1999,
using ICD-9, only 861 of 2133 (40%) deaths among mesothelioma
cases were encoded with malignant pleural tumours as the
underlying cause (3 163.0, 1 163.1, 2 163.8, 855 163.9),
the code category most commonly used for mesothelioma
epidemiological research. Beyond pleural mesotheliomas that
may be being missed, the use of several other body site codes
for malignant neoplasm within the cancer registry deaths is also
apparent (eg peritoneum 2% or unspecified site 19%), potentially
reflecting the occurrence of the less common forms of mesothe-
lioma, outwith the pleura, which are not being picked up by the
163-based codes. The under-reporting of mesotheliomas from
ICD-8/9 based death certificate pleural tumour codes alone is well
recognised (Davis et al, 1992; Iwatsubo et al, 2002). However,
within the UK, it has not caused particular problems due to the
existence of a specific high-quality UK mesothelioma register
(England, Wales and Scotland) that captures any mention of the
term ‘mesothelioma’ from the hand-written death certificates, in
addition to cross-referencing data derived from cancer registry
records (McElvenny et al, 2005). The key significance of knowing
both death certificate data and cancer/mesothelioma registry data
within the same country, relates to the interpretation of reported
mesothelioma-specific death rates, and trends in death rates,
between countries. The detection rate is derived from the
percentage of ‘genuine’ mesotheliomas whose deaths are encoded
as 163. Internationally, different sources of the denominator (the
‘genuine’ number) in published detection rates have been used,
including cases followed-up from cancer registries in the USA
(Davis et al, 1992), specialist mesothelioma registries in Italy and
the UK (Peto et al, 1999; Gorini et al, 2002), and histological series
in France (Iwatsubo et al, 2002). The confirmation rate is derived
from the percentage of 163 coded deaths that appear related to
‘genuine’ mesotheliomas, according to whether they are also
entered as mesotheliomas within cancer or mesothelioma registries
(Davis et al, 1992; Peto et al, 1999), or through case-by-case
explorations of medical notes/pathology (Iwatsubo et al, 2002;
Pinheiro et al, 2003). By employing compensatory calculations
based on, for example, the ratio of mesothelioma to pleural cancer
mortality (confirmation rate divided by detection rate), 163-
encoded death rates between countries can be more informatively
compared (Peto et al, 1999; Gorini et al, 2002).
The 40% detection rate we report, based on Scottish cancer
registry data 1981–1999, is lower than the 55% figure, based on
UK mesothelioma registry data 1986–1991, used by Peto et al
(1999) when assessing trends in mesothelioma mortality rates
across Europe. Although some temporal variation in detection
rates is recognised (Peto et al, 1999), the different sources of
‘genuine’ mesotheliomas used (mesothelioma registry vs cancer
registry) may also be important. The detection rate comparison
was still 40 vs 44%, when 1981–1999 Scottish cancer-registry data
and Scottish mortality data, capturing any text mention of
mesothelioma on the death certificate by supplemental code
(feeding into the UK mesothelioma register) were used, respec-
tively. Although the overall pattern was similar, further subtle
differences in absolute numbers and percentages in the top ten
ICD-9 codes used for underlying cause of death were apparent
when these two different sources of mesothelioma denominator
information were used, despite them being derived from the same
basic population (Table 2). Consequently, there may need to be
additional interpretation of the compensatory calculations used
between countries with different sources for their definitive
incidence numbers. With regard to the specificity of a 163 code,
between 1981 and 1999, 83% (829/997) of Scottish deaths coded
Table 1 Top 10 ICD-9 and ICD-10 codes used for underlying cause of death among Scottish mesothelioma patients (cancer registry data), 1981–2003
Total mesothelioma deaths 1981–1999¼2133 Total mesothelioma deaths 2000–2003¼607
ICD-9 Definition
Observed
(%) ICD-10 Definition
Observed
(%)
163 Malignant neoplasm of pleura 861 (40%) C45.0 Mesothelioma of pleura 311 (51%)
162 Malignant neoplasm of bronchus and lung 475 (22%) C45.9 Mesothelioma, unspecified 75 (12%)
199 Malignant neoplasm, unspecified site 399 (19%) C45.1–45.8 Mesothelioma of other sites 69 (11%)
E866.4 Accidental poisoning by other metals and their
compounds and fumes
79 (4%) X49 Accidental poisoning/exposure to other &
unspecified chemicals & noxious substances
45 (7%)
158 Malignant neoplasm of peritoneum 52 (2%) C34 Malignant neoplasm of bronchus or lung 23 (4%)
501 Asbestosis 45 (2%) C38.4 Malignant neoplasm of pleura 17 (1%)
195.1 Malignant neoplasm of thorax 41 (2%) C76.1 Malignant neoplasm of thorax 9 (1%)
410 Acute myocardial infarction 37 (2%) I21 Acute myocardial infarction 7 (1%)
414 Chronic ischaemic heart disease 18 (1%) I25 Chronic ischaemic heart disease 6 (1%)
485 Bronchopneumonia 14 (1%) C80X Malignant neoplasm, unspecified site 6 (1%)
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on the cancer registry, in line with the UK confirmation rate figure
of 89% used by Peto et al.
Only codes used for the underlying cause of death were
addressed in this study. Previous studies support this approach,
with the inclusion of data outwith the underlying cause of death
field making little (Davis et al, 1992) or no difference (Iwatsubo
et al, 2002) to published mesothelioma detection rates. Partly this
may be due to the fact that the most appropriate underlying cause
in the final encoded data is selected from any field on the death
certificate, either by human or automated software abstraction,
and as mesotheliomas have such a poor prognosis, they may
frequently be chosen as the underlying cause whatever field they
are entered in on the death certificate. To illustrate this, in the 2133
Scottish mesothelioma cases who died between 1981 and 1999,
although 351 had 163 codes in positions other than underlying
cause of death (16%), 289 of these also had 163 listed under the
underlying cause.
Between 2000 and 2003, following the introduction of ICD-10,
75% (455/607) of Scottish mesothelioma deaths using cancer
registry data could be accounted for by the new mesothelioma-
specific C45 codes. This is in line with earlier USA predictions
(80%), and preliminary estimates (82%) based on crude state-
specific population mortality/incidence ratios, made without the
benefit of direct record linkage data (Davis et al, 1992; Pinheiro
et al, 2004). Most of the increased detection in the Scottish data set
appears to result from a drop in the use of codes relating to
‘malignant neoplasm of bronchus and lung’ and ‘malignant
neoplasm, unspecified site’ from 22 to 4%, and 18 to 1%, in
ICD-9 and ICD-10, respectively. Although a certain number of
mesotheliomas listed on death certificates will still be being
missed, through not being identified as the underlying cause of
death, it should be borne in mind that a proportion of the
remaining non-C45 (and non-163 codes under ICD-9) codes will
always be accurate, as not all mesothelioma patients will die from
their mesotheliomas. With regard to the specificity of a C45 death
code, between 2000 and 2002, 95% (379/399) of ICD-10 C45 deaths
were registered as mesotheliomas on the cancer registry.
The proportion of mesothelioma deaths attributable to ischae-
mic heart disease as the underlying cause appears constant
between ICD-9 and ICD-10 at 2–3%. Similarly, the proportion of
deaths attributed to specific accidental poisoning codes (E866.4 in
ICD-9 and X49 in ICD-10) appears fairly constant between 4 and
7%. Although there is some evidence that the risk of accidental and
deliberate self-harm may be increased among those diagnosed with
cancer (Yousaf et al, 2005), the General Register Office for Scotland
reports that these specific codes, covering poisoning by ‘unspeci-
fied’ or ‘other’ causes, are primarily being used as a surrogate for
mesothelioma whenever explicit mention of asbestos exposure was
apparent in the appropriate context of death suggestive of a
mesothelioma (of note, asbestosis per se has different codes). If
such coding patterns are followed internationally and use of these
codes is not extensively employed for other conditions – in
Scotland 81% (79/97) of underlying cause of deaths encoded
E8664, 1981–1999 and 65% (36/55) of deaths encoded X49, 2000–
2003 were listed as mesotheliomas in the cancer registry – 86% (83/
97) and 69% (47/68), respectively based on Scottish mortality data
with supplemental mesothelioma code use – they may represent an
additional way to identify mesothelioma deaths, beyond ICD-9
code 163 and ICD-10 C45, within epidemiological studies in the
future.
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